Start a conversation
Point me at the asset you can't afford to get wrong.
A diligence report on the deal you're weighing, or the value case that makes your asset legible to capital. I read the data, not the deck -- every claim traced to the filing, the trial, or the paper that backs it, on a deadline.
What to send
Three lines get me to a scoped reply. Name the company, ticker, or asset you're evaluating; the scope -- a read on an upcoming readout, a mechanism audit, a competitive landscape, or a full data-room readout; and your timeline. The button below prefills exactly these fields; or just email the address shown and tell me those three things. From there you hand me the pile -- your documents, your data room, whatever you have -- and I wire it to the live record and do the rest.
Engagement formats
- Verified Read$5,000 flat
One asset, fixed scope, ~10 business days. I read the asset against the published record and hand you a verdict with every figure traced to its source.
- Bespoke diligencefrom $10,000
Scoped to your thesis. Mechanism audits, reads on an upcoming readout, deep deal-grade work quoted higher -- the depth the wire decision needs.
Want to see one before you commit? Every report under research is a Verified Read I produced unsolicited -- the same deliverable, on a company I do not work for. The Immunome read is a representative one: a Phase 3 hazard ratio that sounds too good to be true, read against the published record until it holds.
Bespoke work routes through email, then a scope, then an invoice. Diligence is not investment advice.
I take a small number of engagements at a time.
or email me directly:chris@bigbio.aiFollow the research.
New primary-source reports as they ship. No noise.